-
1 Comment
Cisen Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 9.5% below its 200 day moving average.
From a valuation standpoint, the stock is 83.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.6.
Cisen Pharmaceutical Co., Ltd's total revenue sank by 4.6% to $992M since the same quarter in the previous year.
Its net income has dropped by 7.9% to $146M since the same quarter in the previous year.
Finally, its free cash flow fell by 4.4% to $178M since the same quarter in the previous year.
Based on the above factors, Cisen Pharmaceutical Co., Ltd gets an overall score of 1/5.
ISIN | CNE100002VG4 |
---|---|
Exchange | SHG |
CurrencyCode | CNY |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Target Price | None |
---|---|
PE Ratio | 18.96 |
Beta | 0.31 |
Market Cap | 9B |
Dividend Yield | None |
Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, research, develops, produces, and sells drug products in China and internationally. The company's chemical preparations include basic infusion, therapeutic infusion, liver disease medication, nervous system drugs, anti-tumor and adjuvant drugs, nutritional infusion, contrast agents, cardiovascular and cerebrovascular drugs, anti-infective drugs, narcotic analgesics, obstetrics and gynecology medication, digestive system medication, respiratory system medication, immune system drugs, and hormonal drugs. It also offers Chinese medicine preparations; complete and incomplete nutritional formula food; specific nutritionally complete formula foods; nutritious food; health food; API; and packaging products. The company was formerly known as Shandong Lukang Cisen Pharmaceutical Co., Ltd. and changed its name to Cisen Pharmaceutical Co., Ltd. in 2011. Cisen Pharmaceutical Co., Ltd. was founded in 1970 and is headquartered in Jining, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603367.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025